NOSIUM (NOSIUM ) Q3 2024 earnings summary

Executive summary

• Net sales declined sharply both in Q3 and year-to-date, with significant operating and net losses reported for both the parent company and the group compared to the previous year.

• Major portfolio restructuring underway, including a planned reverse acquisition of BG Holding AB and a directed share issue to raise SEK 2 million.

• The company is focusing on core operations and considering divestments of non-core holdings to optimize resources.

Financial highlights

• Group Q3 net sales: SEK 1,336k (down 72% year-over-year); operating result: SEK -1,623k; net result attributable to parent shareholders: SEK -5,296k.

• Parent Q3 net sales: SEK 85k (down 93% year-over-year); operating result: SEK -815k; net result: SEK -4,435k.

• Year-to-date group net sales: SEK 5,718k (down 61% year-over-year); operating result: SEK -6,045k; net result: SEK -12,015k.

• Cash flow from operations (Q3): Group SEK -1,594k; Parent SEK -270k.

• Equity ratio at group level: 76% (up from 63% year-over-year).

Outlook and guidance

• Management expresses optimism about the future, citing strengthened financial position from recent share issues and anticipated benefits from the BG Holding reverse acquisition.

• The company aims to create shareholder value by focusing on core business and strategic portfolio optimization.